Mark A. Varney
Founder at Neurolixis, Inc.
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Jeff Margolis | M | 68 | 11 years | |
| Arnold Lippa | M | 77 | 11 years | |
| Adrian Newman-Tancredi | M | - |
Neurolixis, Inc.
 Neurolixis, Inc. Miscellaneous Commercial ServicesCommercial Services Neurolixis, Inc. is an early-stage biopharmaceutical company that focuses on discovering and developing novel drugs for the treatment of central nervous system disorders such as Parkinson's disease, Rett syndrome, depression, and pain. Neurolixis is based in Dana Point, CA. The private company is developing a platform of early-stage drug candidates that target serious CNS diseases with unmet medical needs and a sizable market opportunity. The company's compounds are based on the concept of serotonin 5-HT1A receptor "biased agonism," which enables drugs to more precisely target specific brain regions controlling CNS disorders. The company was founded by Mark A. Varney and Adrian Newman-Tancredi, and Adrian Newman-Tancredi has been the CEO since incorporation. | - |
| Mark S. Kleven | M | - |
Neurolixis, Inc.
Neurolixis, Inc. Miscellaneous Commercial ServicesCommercial Services Neurolixis, Inc. is an early-stage biopharmaceutical company that focuses on discovering and developing novel drugs for the treatment of central nervous system disorders such as Parkinson's disease, Rett syndrome, depression, and pain. Neurolixis is based in Dana Point, CA. The private company is developing a platform of early-stage drug candidates that target serious CNS diseases with unmet medical needs and a sizable market opportunity. The company's compounds are based on the concept of serotonin 5-HT1A receptor "biased agonism," which enables drugs to more precisely target specific brain regions controlling CNS disorders. The company was founded by Mark A. Varney and Adrian Newman-Tancredi, and Adrian Newman-Tancredi has been the CEO since incorporation. | - |
| James Matteucci | M | - | 21 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Robert P. Luciano | M | - | 23 years | |
| Roger Stoll | M | 81 | 10 years | |
| Maria S. Messinger | F | 56 | 18 years | |
| Charles Casamento | M | 78 | 16 years | |
| Ismail Kola | M | 67 | 4 years | |
| Robert F. Allnutt | M | 88 | 17 years | |
| Thomas Shenk | M | 77 | 11 years | |
| Thomas A. Reed | M | - |
Sibia Neurosciences, Inc.
| 19 years |
| Wendy Yarno | F | 68 | 9 years | |
| Laura Sepp-Lorenzino | M | 63 | 15 years | |
| Jeffrey F. McKelvey | M | - |
Sibia Neurosciences, Inc.
| - |
| M. Ross Johnson | M | 79 | 11 years | |
| Peter Frank Drake | M | - | 9 years | |
| David Anstice | M | 75 | 5 years | |
| Anne Tatlock | F | 84 | - | |
| William Harrison | M | 80 | - | |
| John F. Benedik | M | 76 | 8 years | |
| Robert W. Verdugo | M | - | 3 years | |
| Peter Honig | M | 67 | 7 years | |
| Michael Atieh | M | 70 | 19 years | |
| Dorothy P. Bowers | F | - | - | |
| Egil Bodd | M | 69 | 11 years | |
| John Yates | M | 67 | 13 years | |
| Kathryn B. Hyer | F | - | - | |
| Franz Hefti | M | 76 | 7 years | |
| Leslie J. Street | M | 65 | - | |
| Bernard J. Kelley | M | 82 | 10 years | |
| Peggy Angeles | F | - |
Sibia Neurosciences, Inc.
| - |
| Sarah S. Toomey | F | 50 | 3 years | |
| Eric Schadt | M | 59 | 8 years | |
| Weichang Zhou | M | 59 | 8 years | |
| Yaacov Weinstock | M | - | 1 years | |
| Gerard Cunningham | M | - | 1 years | |
| Edward Berg | M | - | 8 years | |
| Tom Caskey | M | - | 6 years | |
| John Renger | M | 55 | 15 years | |
| Katherine Beebe-DeVarney | M | 63 | 2 years | |
| Amit Hasija | M | 51 | 5 years | |
| Jens Renstrup | M | 59 | 8 years | |
| Judith Dunn | M | 62 |
Sumitomo Pharma America, Inc.
 Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Sumitomo Pharma America, Inc. operates as a biopharmaceutical company that develops pharmaceutical products. Its products include Aptiom (eslicarbazepine acetate) tablets, Latuda (lurasidone HCl) tablets, Lunesta (eszopiclone) tablets, Xopenex (levalbuterol HCl) Inhalation Solution, Xopenex HFA (levalbuterol tartrate) Inhalation Aerosol, Brovana (arformoterol tartrate) Inhalation Solution, Omnaris (ciclesonide) Nasal Spray, Alvesco (ciclesonide) Inhalation Aerosol, and Zetonna (ciclesonide) Nasal Aerosol. The company was founded in 2010 and is headquartered in Marlborough, MA. | 5 years |
| Juan Camilo Arjona Ferreira | M | 54 | 12 years | |
| Paul Ronald Bell | M | 76 | 14 years | |
| Benito Munoz | M | 62 | 9 years | |
| Jacob Harel | M | 69 | 13 years | |
| Barbara Yanni | F | 69 | 13 years | |
| Glenn Williams | M | - | 10 years | |
| Zhi Sheng Chen | M | 52 | 5 years | |
| Cynthia Smith | F | 55 | 8 years | |
| David W. Carley | M | - | - | |
| James H. Coleman | M | 82 | 12 years | |
| Simon D. Kelner | M | 51 | 13 years | |
| Steven Nichtberger | M | 62 | 8 years | |
| Guy MacDonald | M | 65 | 22 years | |
| Ed M. Scolnick | M | 83 | 20 years | |
| Marcia Avedon | M | 62 | 4 years | |
| Patrick Yang | M | 75 | 11 years | |
| Ronald Newbold | M | 61 | 9 years | |
| Albert I. Wertheimer | M | 81 | 3 years | |
| Harry Mansbach | M | 59 | 2 years | |
| David Arkowitz | M | 62 | 3 years | |
| Peter G. Ernster | M | 82 | 26 years | |
| Joan Wainwright | F | 63 | 6 years | |
| J. Carroll | M | 74 | 25 years | |
| James Christopher Scalet | M | 65 | 9 years | |
| Wendy Dixon | M | 68 | 5 years | |
| William Peters | M | 56 | 3 years | |
| William T. Comer | M | 85 |
Sibia Neurosciences, Inc.
| 8 years |
| Gary Allen Rogers | M | 79 | 7 years | |
| Beth Seidenberg | M | 67 | 2 years | |
| Roger Perlmutter | M | 71 | 4 years | |
| Elizabeth Hamilton Seabury Wyatt | M | 76 | 20 years | |
| Pierre V. Trân | M | 64 | 3 years | |
| Peter W. Letendre | M | 66 | - | |
| Ian M. Miller | M | - | 11 years | |
| William Daley | M | 75 | 4 years | |
| Eric Fraser Ainsworth | M | 77 | 7 years | |
| Linda Burns | F | - | 1 years | |
| Frank Verwiel | M | 61 | 4 years | |
| Alan Sachs | M | - | - | |
| Alan Nies | M | 86 | 10 years | |
| Ronald B. Moss | M | 64 | 1 years | |
| David S. Doll | M | - | 8 years | |
| Vijay Samant | M | 77 | 23 years | |
| Hugh Johnston | M | 62 | 3 years | |
| Gerald McLaughlin | M | 56 | 11 years | |
| Timothy James Rink | M | 78 |
Sumitomo Pharma America, Inc.
Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Sumitomo Pharma America, Inc. operates as a biopharmaceutical company that develops pharmaceutical products. Its products include Aptiom (eslicarbazepine acetate) tablets, Latuda (lurasidone HCl) tablets, Lunesta (eszopiclone) tablets, Xopenex (levalbuterol HCl) Inhalation Solution, Xopenex HFA (levalbuterol tartrate) Inhalation Aerosol, Brovana (arformoterol tartrate) Inhalation Solution, Omnaris (ciclesonide) Nasal Spray, Alvesco (ciclesonide) Inhalation Aerosol, and Zetonna (ciclesonide) Nasal Aerosol. The company was founded in 2010 and is headquartered in Marlborough, MA. | 4 years |
| Erskine B. Bowles | M | 78 | 2 years | |
| Heidi Miller | M | 70 | 4 years | |
| Moogak Hwang | M | - | 1 years | |
| Barry Gumbiner | M | 68 | 6 years | |
| Mark E. McDonough | M | 59 | - | |
| Sean Dobson | M | - | 5 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 96 | 98.97% |
| Australia | 1 | 1.03% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Mark A. Varney
- Personal Network
